Medicações de Alta Vigilância: como minimizar a ocorrência de erros

Abstract

Introduction: High vigilance medications AVMs emerged through the need to standardize medications that are highly dangerous to patients, which must be handled more rigidly so that errors do not occur. Objective: This article aims to carry out a survey of the literature, which addresses ways to minimize the occurrence of errors in the use of high-alert AVM medications. Method: Through a narrative literature review, 14 studies were reviewed and selected, including scientific articles, national protocols and bulletins, which address the subject, in order to answer the question “How to minimize the occurrence of errors in the administration of high vigilance medications? Results: Research indexes were presented that address the impacts caused by the occurrence of errors regarding AVMs, their main reasons and impacts. Thus, also listing minimization strategies, regarding continuous education and training, use of assistive technologies, safety culture, promotion and implementation of protocols and their monitoring. Final considerations: Minimizing the occurrence of errors with high-alert medications is an ongoing challenge in clinical practice. The role of nursing is fundamental in this process, through continuous education, the use of assistive technologies, the promotion of a culture of safety, the implementation of protocols and their monitoring. It is necessary to engage all health professionals to implement effective measures and ensure safe use of these medications.